SOBRsafe Inc. (NASDAQ: SOBR) Receives Initial Purchase Order for Alcohol Detection Wristbands from ALYST Health, Boosting Visibility in Behavioral Health Space
- SOBRsafe, a provider of next-generation transdermal alcohol detection and monitoring technology, is currently focusing on behavioral health, justice and licensing
- ALYST Health, a company that offers concierge addiction treatment services, recently made an initial purchase of the SOBRsure(TM) alcohol detection wristbands and has begun integrating them for client use
- SOBRsure is a fitness-style passive alcohol monitoring wristband designed for advanced alcohol safety, support and recovery for individuals
- The wristband comes with numerous features, including privacy-focused continuous remote monitoring, alcohol detection, app-based reporting, GPS tracking and removal alerts
- SOBRsafe’s hardware products connect to powerful real-time reporting software through which the devices deliver immediate insights, ensuring alcohol monitoring with dignity
SOBRsafe (NASDAQ: SOBR), a provider of next-generation transdermal (touch-based) alcohol detection technology, recently announced that ALYST Health, a company that offers the first and only fully at-home addiction treatment program accredited by the Joint Commission, has made an initial purchase of the SOBRsure(TM) alcohol detection wristbands for use in its concierge addiction treatment services. According to the announcement, ALYST has already begun integrating the wristbands for client use (https://nnw.fm/J83ih ).
Launched in October 2023, SOBRsure is a fitness-style passive alcohol monitoring wristband designed for advanced alcohol safety, support and recovery for individuals (https://nnw.fm/WqJ7A ). Like SOBRsafe’s other solution, the SOBRcheck(TM), SOBRsure operates on the principle of transdermal science to detect alcohol consumption. It is based on the proven fact that the body excretes a small but measurable amount – about 2-5% (https://nnw.fm/PgQmV ) – of alcohol whenever a person consumes alcohol; transdermal excretion, which SOBRsafe’s products target, begins about 20 minutes after drinking.
The amount of alcohol excreted through the skin, SOBRsafe says, creates “a strong correlation between Transdermal Alcohol Content (“TAC”) and Blood Alcohol Concentration (“BAC”)/Breath Alcohol Concentration (“BrAC”).” According to the company, SOBRsure uses an electrochemical sensor to generate readings in alcohol parts per million, “ensuring accuracy and eliminating human error.”
The SOBRsure wristband ships with numerous features, including privacy-focused continuous remote monitoring, alcohol detection, app-based reporting, GPS tracking and removal alerts. These features make the wristband perfect for individuals who have just been discharged from rehab or participants in at-home addiction treatment programs. “If you have a drink, it signals your telehealth professional, and they can try to help you before you get into a crisis,” explained SOBRsafe Chairman and CEO Dave Gandini in an interview with Denver7, an ABC affiliate (https://nnw.fm/qjDPI ).
The remote monitoring capabilities of SOBRsure drew ALYST, which is adopting the wristband for its at-home addiction treatment services. “Conventional treatment centers – and conventional monitoring methods – aren’t always a good fit for many people who value privacy, personalized treatment, or their daily routine,” commented ALYST Founder and CEO Richard Blair. “This is why we feel SOBRsure is an ideal addition to our program, which moves the point of care from the treatment center to the comfort and privacy of a client’s home – without sacrificing quality. SOBRsure brings dignity and convenience to remote monitoring, and we believe it will further empower recovery success.”
ALYST is the latest company from the behavioral health space to adopt SOBRsafe’s solutions, further reinforcing SOBR’s commitment to serving the behavioral health and justice markets. Speaking at the Lytham Partners Investor Select Conference, Gandini stated that management of the SOBRsafe, which previously targeted a different market altogether, decided to redirect its focus to the behavioral health space as its primary target market following interactions with hundreds of individuals, companies and prospective clients (https://nnw.fm/K7ALE ).
Behavioral health refers to a wide-reaching field that is concerned with mental health, substance use disorders, lifestyle, interpersonal relationships and more. A primary area of focus is behavioral health providers that have existing alcohol screening procedures.
One of the ways these providers have traditionally employed to monitor their patients is with breathalyzers. But breathalyzers are unhygienic, cumbersome to administer and require the presence of an official to administer the tests and record the results. Breathalyzers, Gandini explains, may increase the levels of stress and induce anxiety among the test-takers who have to take the tests in front of one or more administrators and or other patients. Their administration can also breach patients’ privacy and erode their dignity.
SOBRsafe is out to address these issues, positioning its alcohol monitoring or detection devices as more dignified, privacy-focused, hygienic and efficient alternatives to breathalyzers. Approximately 46,000 brick-and-mortar facilities in operation across the United States, each needing a way to monitor their patients. This represents a market SOBRsafe hopes to universally serve, one facility at a time.
For more information, visit the company’s website at www.SOBRsafe.com.
NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://nnw.fm/SOBR
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- SOBRsafe, a provider of next-generation transdermal alcohol detection and monitoring technology, is currently focusing on behavioral health, justice and licensing
- ALYST Health, a company that offers concierge addiction treatment services, recently made an initial purchase of the SOBRsure(TM) alcohol detection wristbands and has begun integrating them for client use
- SOBRsure is a fitness-style passive alcohol monitoring wristband designed for advanced alcohol safety, support and recovery for individuals
- The wristband comes with numerous features, including privacy-focused continuous remote monitoring, alcohol detection, app-based reporting, GPS tracking and removal alerts
- SOBRsafe’s hardware products connect to powerful real-time reporting software through which the devices deliver immediate insights, ensuring alcohol monitoring with dignity
SOBRsafe (NASDAQ: SOBR), a provider of next-generation transdermal (touch-based) alcohol detection technology, recently announced that ALYST Health, a company that offers the first and only fully at-home addiction treatment program accredited by the Joint Commission, has made an initial purchase of the SOBRsure(TM) alcohol detection wristbands for use in its concierge addiction treatment services. According to the announcement, ALYST has already begun integrating the wristbands for client use (https://nnw.fm/J83ih ).
Launched in October 2023, SOBRsure is a fitness-style passive alcohol monitoring wristband designed for advanced alcohol safety, support and recovery for individuals (https://nnw.fm/WqJ7A ). Like SOBRsafe’s other solution, the SOBRcheck(TM), SOBRsure operates on the principle of transdermal science to detect alcohol consumption. It is based on the proven fact that the body excretes a small but measurable amount – about 2-5% (https://nnw.fm/PgQmV ) – of alcohol whenever a person consumes alcohol; transdermal excretion, which SOBRsafe’s products target, begins about 20 minutes after drinking.
The amount of alcohol excreted through the skin, SOBRsafe says, creates “a strong correlation between Transdermal Alcohol Content (“TAC”) and Blood Alcohol Concentration (“BAC”)/Breath Alcohol Concentration (“BrAC”).” According to the company, SOBRsure uses an electrochemical sensor to generate readings in alcohol parts per million, “ensuring accuracy and eliminating human error.”
The SOBRsure wristband ships with numerous features, including privacy-focused continuous remote monitoring, alcohol detection, app-based reporting, GPS tracking and removal alerts. These features make the wristband perfect for individuals who have just been discharged from rehab or participants in at-home addiction treatment programs. “If you have a drink, it signals your telehealth professional, and they can try to help you before you get into a crisis,” explained SOBRsafe Chairman and CEO Dave Gandini in an interview with Denver7, an ABC affiliate (https://nnw.fm/qjDPI ).
The remote monitoring capabilities of SOBRsure drew ALYST, which is adopting the wristband for its at-home addiction treatment services. “Conventional treatment centers – and conventional monitoring methods – aren’t always a good fit for many people who value privacy, personalized treatment, or their daily routine,” commented ALYST Founder and CEO Richard Blair. “This is why we feel SOBRsure is an ideal addition to our program, which moves the point of care from the treatment center to the comfort and privacy of a client’s home – without sacrificing quality. SOBRsure brings dignity and convenience to remote monitoring, and we believe it will further empower recovery success.”
ALYST is the latest company from the behavioral health space to adopt SOBRsafe’s solutions, further reinforcing SOBR’s commitment to serving the behavioral health and justice markets. Speaking at the Lytham Partners Investor Select Conference, Gandini stated that management of the SOBRsafe, which previously targeted a different market altogether, decided to redirect its focus to the behavioral health space as its primary target market following interactions with hundreds of individuals, companies and prospective clients (https://nnw.fm/K7ALE ).
Behavioral health refers to a wide-reaching field that is concerned with mental health, substance use disorders, lifestyle, interpersonal relationships and more. A primary area of focus is behavioral health providers that have existing alcohol screening procedures.
One of the ways these providers have traditionally employed to monitor their patients is with breathalyzers. But breathalyzers are unhygienic, cumbersome to administer and require the presence of an official to administer the tests and record the results. Breathalyzers, Gandini explains, may increase the levels of stress and induce anxiety among the test-takers who have to take the tests in front of one or more administrators and or other patients. Their administration can also breach patients’ privacy and erode their dignity.
SOBRsafe is out to address these issues, positioning its alcohol monitoring or detection devices as more dignified, privacy-focused, hygienic and efficient alternatives to breathalyzers. Approximately 46,000 brick-and-mortar facilities in operation across the United States, each needing a way to monitor their patients. This represents a market SOBRsafe hopes to universally serve, one facility at a time.
For more information, visit the company’s website at www.SOBRsafe.com.
NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://nnw.fm/SOBR
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
